| Literature DB >> 28645322 |
Arne Mehl1,2,3, Bjørn Olav Åsvold4,5,6, Angela Kümmel7, Stian Lydersen8, Julie Paulsen9,4,10, Ingvild Haugan11, Erik Solligård4,12,13, Jan Kristian Damås4,10,14, Stig Harthug15,16, Tom-Harald Edna17,18.
Abstract
Entities:
Year: 2017 PMID: 28645322 PMCID: PMC5481901 DOI: 10.1186/s12879-017-2545-z
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Fig. 3Number of BSI episodes with microbe(s) non-susceptible to penicillin-gentamicin-metronidazole (PGM) through three time periods. Additional file 1: Table S5 shows the PGM non-susceptible microbes in detail. The percentages of episodes with microbe(s) non-susceptible to PGM were 1.9%, 3.0%, and 5.2% in 2002–2005, 2006–2009, and 2010–2013, respectively. ANS, acquired non-susceptibility; INS, inherent non-susceptibility